Published in J Korean Med Sci on October 16, 2015
Diagnosis, management, and treatment of hepatitis C: an update. Hepatology (2009) 22.53
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol (2013) 4.46
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med (1996) 4.10
Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study. Liver Transpl (2006) 2.12
Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology (2005) 1.97
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl (2006) 1.86
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86
Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol (2013) 1.86
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl (2011) 1.85
Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol (2007) 1.76
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology (2011) 1.59
Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C. Am J Transplant (2013) 1.58
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian patients. J Gastroenterol Hepatol (2011) 1.45
Hepatitis C virus treatment pre- and post-liver transplantation. Liver Int (2012) 1.30
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant (2006) 1.20
Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin. J Clin Virol (2011) 1.13
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies. J Viral Hepat (2008) 1.11
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy. J Hepatol (2014) 1.10
Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: "a flood of opportunity". Am J Transplant (2014) 1.09
Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation. Am J Transplant (2011) 1.07
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant (2005) 1.06
Liver transplantation and hepatitis C. Clin Res Hepatol Gastroenterol (2011) 1.04
Management of HCV transplant patients with triple therapy. Liver Int (2014) 0.99
Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci (2002) 0.90
Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation (2004) 0.89
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation. Med Microbiol Immunol (2009) 0.87
Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis. Liver Transpl (2013) 0.85
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach. Liver Transpl (2013) 0.84
Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation. Cochrane Database Syst Rev (2010) 0.83
New insights in recurrent HCV infection after liver transplantation. Clin Dev Immunol (2013) 0.83
Role of interleukin-28B genetic polymorphisms in Korean patients with hepatitis C virus infection. Gut Liver (2013) 0.83
Strategies to reduce hepatitis C virus recurrence after liver transplantation. World J Hepatol (2013) 0.82
Treatment of chronic hepatitis C virus infection after liver transplantation. Dig Liver Dis (2013) 0.80
Analysis of the recurrence of hepatitis C virus after liver transplantation: results of the Andalusian liver registry. Transplant Proc (2013) 0.78
Challenges of recurrent hepatitis C in the liver transplant patient. World J Gastroenterol (2014) 0.77
A modified ribavirin-free interferon therapy with boceprevir in post-liver transplant recurrent hepatitis C. J Clin Gastroenterol (2014) 0.77
[Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years]. Orv Hetil (2013) 0.76
The importance of IL28B genotype in hepatitis C virus-associated liver transplantation. Liver Int (2013) 0.76
Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl (2009) 1.79
Three-quarters of right liver donors experienced postoperative complications. Liver Transpl (2007) 1.70
An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantation. Liver Transpl (2007) 1.61
Classification and prognosis of intrahepatic biliary stricture after liver transplantation. Liver Transpl (2007) 1.21
Clinical outcomes of and patient satisfaction with different incision methods for donor hepatectomy in living donor liver transplantation. Liver Transpl (2015) 0.86
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl (2007) 0.83
A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase. Korean J Intern Med (2014) 0.83
Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases. Ann Surg Treat Res (2014) 0.82
The safety of a laparoscopic cholecystectomy in acute cholecystitis in high-risk patients older than sixty with stratification based on ASA score. Minim Invasive Ther Allied Technol (2006) 0.82
Long term outcomes of pediatric liver transplantation according to age. J Korean Med Sci (2014) 0.81
Hypophosphatemia after live donor right hepatectomy. Surgery (2008) 0.80
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. Clin Mol Hepatol (2014) 0.80
A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res (2014) 0.80
Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Liver Int (2015) 0.79
Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors. Transpl Int (2013) 0.79
Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy? Korean J Hepatobiliary Pancreat Surg (2011) 0.79
Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT. J Nucl Med (2016) 0.78
Comparison of volume-reductive therapies for massive polycystic liver disease in autosomal dominant polycystic kidney disease. Hepatol Res (2015) 0.78
Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma. J Korean Med Sci (2014) 0.78
Living donor liver transplantation for an infant with osteogenesis imperfecta and intrahepatic cholestasis: report of a case. J Korean Med Sci (2014) 0.78
Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging. Ann Surg Treat Res (2015) 0.76
Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2015) 0.76
Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clin Mol Hepatol (2014) 0.76
Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of TRIM22. Gut (2017) 0.76
Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol (2016) 0.75
Fatigue and related factors after liver transplantation. Korean J Hepatobiliary Pancreat Surg (2015) 0.75
Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence. J Pathol Transl Med (2016) 0.75
Metastatic follicular struma ovarii complicating pregnancy: a case report and review of the literature. Korean J Hepatobiliary Pancreat Surg (2012) 0.75
The correlation between preoperative volumetry and real graft weight: comparison of two volumetry programs. Ann Surg Treat Res (2017) 0.75
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients. J Korean Med Sci (2017) 0.75
Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume. J Korean Med Sci (2014) 0.75
Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy. J Pathol Transl Med (2016) 0.75
Feasibility of implementing a surgical student internship program in South Korea. Ann Surg Treat Res (2015) 0.75
Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation. J Korean Med Sci (2017) 0.75
Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center. Korean J Pediatr (2017) 0.75
Living Related Liver Transplantation in an Infant with Neonatal Hemochromatosis. Pediatr Gastroenterol Hepatol Nutr (2016) 0.75
Preparation for high altitude expedition and changes in cardiopulmonary and biochemical laboratory parameters with ascent to high altitude in transplant patients and live donors. Clin Transplant (2015) 0.75
Delayed transplantation may affect intellectual ability in children. Pediatr Int (2017) 0.75
Identification of a safe and adequate division point of the left-sided bile duct with magnetic resonance cholangiography during donor left lateral sectionectomy. Surgery (2015) 0.75
Contrast-Enhanced Ultrasound Using Perfluorobutane-Containing Microbubbles in the Assessment of Liver Allograft Damage: An Exploratory Prospective Study. Ultrasound Med Biol (2016) 0.75